NCT04566406

Brief Summary

The aims of our study were to define perioperative HI during laparoscopic adrenalectomy for pheochromocytoma, assess the incidence of perioperative HI, and identify predictive factors of perioperative HI in our group of patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2003

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2003

Completed
16.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

September 17, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 28, 2020

Completed
Last Updated

September 28, 2020

Status Verified

September 1, 2020

Enrollment Period

16.9 years

First QC Date

September 17, 2020

Last Update Submit

September 22, 2020

Conditions

Keywords

pheochromocytomalaparoscopyhaemodynamicssurgery

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with Hemodynamic Instability (n, %)

    Hemodynamic instability was defined as an occurrence of both intraoperative episodes of systolic blood pressure above 160 mm Hg and vasoactive (vasodilators or vasoconstrictors) drugs administration. Patients were divided into two groups: one which met both above criteria, and another one without hemodynamic instability.

    intraoperative

Secondary Outcomes (2)

  • Number of Complications in Patients (n, %)

    Within 30 days after surgery

  • Number of Cardiovascular Complications in Patients (n, %)

    Within 30 days after surgery

Other Outcomes (11)

  • Length of hospital stay (days)

    Up to 30 days

  • Duration of anaesthesia (min)

    Intraoperative

  • Duration of surgery (min)

    Intraoperative

  • +8 more other outcomes

Interventions

Preoperative staging in all cases consisted of computed tomography or/and magnetic resonance imaging. Prior to surgery, a routine panel of laboratory tests was carried out. The catecholamines metabolites (metanephrine, normetanephrine, and methoxytyramine) were measured from 24-hour urine collection. All patients were preoperatively treated with phenoxybenzamine or alternative doxazosin.Additionally, beta-blockers in case of coexisting tachycardia were given. In the morning of the operation, preinduction blood pressure was measured. Pneumoperitoneum was achieved by insufflating CO2 gas to an intraperitoneal pressure of 12 mmHg. The operative method in our department was laparoscopic transperitoneal lateral total adrenalectomy. Intraoperatively SBP and diastolic blood pressure (DBP) were measured and recorded every 10 minutes. To treat hypertensive and hypotensive episodes, intravenous doses of urapidil, ephedrine, nitrates, MgSO4, norepinephrine, or ß-blockers were administered.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with histologically confirmed pheochromocytoma undergoing laparoscopic adrenalectomy

You may qualify if:

  • patients with histologically confirmed pheochromocytoma undergoing laparoscopic adrenalectomy

You may not qualify if:

  • bilateral tumour
  • no histopathological result
  • neoplastic spread

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

PheochromocytomaHypertension

Condition Hierarchy (Ancestors)

ParagangliomaNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve TissueVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 17, 2020

First Posted

September 28, 2020

Study Start

January 1, 2003

Primary Completion

December 1, 2019

Study Completion

September 1, 2020

Last Updated

September 28, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share